EAM Investors’s Kura Oncology KURA Stock Holding History

EAM Investors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-58,409	Closed	-$1.91M	–	394
2020 Q4	$1.91M	Sell	58,409 -86,213	-60%	-$3.03M	0.31%	132
2020 Q3	$4.43M	Buy	+144,622	New	+$3.19M	1.05%	6
2018 Q2	–	Sell	-78,146	Closed	-$1.47M	–	321
2018 Q1	$1.47M	Sell	78,146 -38,478	-33%	-$749K	0.24%	162
2017 Q4	$1.78M	Sell	116,624 -76,300	-40%	-$1.12M	0.32%	151
2017 Q3	$2.88M	Buy	+192,924	New	+$1.81M	0.38%	75

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM Investors's KURA Position: Q1 2021 in Review

EAM Investors sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 58,409 shares — an estimated $1.91M sold.

EAM Investors first reported a position in KURA in Q3 2017 and held it in 5 quarters. The position peaked at $4.43M in Q3 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

EAM Investors reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
EAM Investors sold 58,409 Kura Oncology shares in Q1 2021, an estimated $1.91M.
EAM Investors first reported a position in Kura Oncology in Q3 2017 and held it in 5 quarters.
EAM Investors's Kura Oncology position peaked at $4.43M in Q3 2020.
171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.